Company

Sichuan Biokin's Izalontamab Brengitecan (BL‑B01D1) Gains NMPA Acceptance for HR+/HER2‑ Breast Cancer NDA – Phase III PFS Win Drives Third Tumor‑Type Expansion Bid
ADC / XDCBiokin Pharmaceutical

Sichuan Biokin’s Izalontamab Brengitecan (BL‑B01D1) Gains NMPA Acceptance for HR+/HER2‑ Breast Cancer NDA – Phase III PFS Win Drives Third Tumor‑Type Expansion Bid

Sichuan Biokin Pharmaceutical Co., Ltd. (SHA: 688506) announced that China's National Medical Products Administration (NMPA) has officially accepted the marketing application for a new indication of Izalontamab Brengitecan (BL‑B01D1 /…

Gilead to Acquire Oral IL‑23R Inhibitor HCXT‑2001 from PepStar Therapeutics for USD 1.275 Billion Upfront – Deepening Inflammation Pipeline with Long‑Acting Macrocyclic Peptide

Gilead to Acquire Oral IL‑23R Inhibitor HCXT‑2001 from PepStar Therapeutics for USD 1.275 Billion Upfront – Deepening Inflammation Pipeline with Long‑Acting Macrocyclic Peptide

Everest Medicines Secures TFDA Approval for Velsipity (etrasimod) in Ulcerative Colitis – Completion of All Authorized Territories Across Greater China and South Korea

Everest Medicines Secures TFDA Approval for Velsipity (etrasimod) in Ulcerative Colitis – Completion of All Authorized Territories Across Greater China and South Korea

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Dren Bio, Sanofi Forge $1.8B B‑Cell Therapy Deal with US Co‑Promote Option
Dren BioNASDAQ: SNY

Dren Bio, Sanofi Forge $1.8B B‑Cell Therapy Deal with US Co‑Promote Option

Adaptive Licenses TCR Data to Pfizer in $890M Deal for Rheumatoid Arthritis
Adaptive BiotechnologiesAI

Adaptive Licenses TCR Data to Pfizer in $890M Deal for Rheumatoid Arthritis

Hengrui NMPA Approves Four Clinical Trials Advancing Oncology and Metabolic Pipeline
CancerClinical trial approval / initiation

Hengrui NMPA Approves Four Clinical Trials Advancing Oncology and Metabolic Pipeline

GSK's Nucala Wins CHMP Nod for COPD in Europe
GlaxoSmithKlineGSK

GSK’s Nucala Wins CHMP Nod for COPD in Europe

Show More